No profile data available.
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is a healthcare company in the nutritional and natural health products industry, based in Wan Chai, Hong Kong, with about 23 full-time employees.
It reported revenue of $2.28 million for fiscal year 2024, up 37.0% from fiscal year 2023, and net income of $302,210. Its market capitalization was $35.75 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2024; market data as of October 8, 2026.
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization.
Zhong Yuan Bio-Technology Holdings reported $2.28 million in revenue for fiscal year 2024, up 37.0% from $1.66 million in fiscal year 2023.
$35.75 million as of October 8, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Goldenwell Biotech, Inc. (GWLL), Clene Inc. (CLNN), Harvard Apparatus Regenerative Technology Inc. (HRGN), Holistic Asset Finance Group Co., Ltd. (HAFG).